Annual Revenue ()

Bayer revenue was €35.02 b in FY, 2017 which is a 25.1% year over year decrease from the previous period.

Quarterly Revenue ()

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017
Revenue€40.16 b€41.34 b€46.32 b€46.77 b€35.02 b
Growth2.95%12.06%0.96%(25.13%)
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017
Revenue€11.85 b€11.83 b€8.26 b€13.24 b€12.19 b€8.03 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Bayer revenue breakdown by business segment: 27.4% from CropScience , 48.1% from Pharmaceuticals, 16.7% from Consumer Health and 7.8% from Other

Bayer revenue breakdown by geographic segment: 38.2% from Europe / Middle East / Africa, 29.0% from North America, 21.8% from Asia / Pacific and 11.0% from Latin America

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017
Healthcare18.92 b19.08 b22.87 b
CropScience 8.82 b9.49 b10.37 b9.95 b9.58 b
MaterialScience 11.24 b
Reconciliation 1.18 b1.12 b1.10 b
Covestro11.65 b11.98 b11.90 b
Pharmaceuticals16.45 b16.85 b
Animal Health1.53 b1.57 b
Consumer Health6.04 b5.86 b
Other 3.17 b1.14 b
Corporate Functions and Consolidation16 m
FY, 2017
Europe / Middle East / Africa13.39 b
North America10.14 b
Asia / Pacific7.64 b
Latin America3.85 b